Contract Year 2027 Policy and Technical Changes to the Medicare Advantage and Medicare Prescription Drug Benefit Program (Part c and D proposed rule)

MMAPA

Jun 26

1 min read

Updated: Jul 27

This letter outlines MMAPA´s comments on the 2027 Medicare Advantage and Part D

Final Rule, with particular emphasis on policies affecting Puerto Rico. It discusses the

importance of preserving flexibility for Dual Eligible Special Needs Plans (D-SNPs),

maintaining beneficiary choice, and ensuring federal policies support a stable and

competitive Medicare Advantage program on the Island.

Recent Posts

See All

Congressional Letter on MA Benchmark Floor for PR - Rep. Murphy

MMAPA´s comments on the CY 2027 Medicare Advantage Advance Notice

MMAPA´s comments on the CY 2027 Medicare Advantage Advance Notice In this document, MMAPA outlines its recommendations to CMS on proposed Medicare Advantage payment and policy changes for 2027. The co

MMAPA letter to CMS regarding D-SNP

Letter to CMS on Protecting Choice for Puerto Rico´s Dual-Eligible Beneficiaries This letter outlines MMAPA´s recommendations to CMS to preserve beneficiary choice and competition within Puerto Rico´s

Comments